Delegating revocations and authorizations in collaborative business environments

Efficient collaboration allows organizations and individuals to improve the efficiency and quality of their business activities. Delegations, as a significant approach, may occur as workflow collaborations, supply chain collaborations, or collaborative commerce. Role-based delegation models have been used as flexible and efficient access management for collaborative business environments. Delegation revocations can provide significant functionalities for the models in business environments when the delegated roles or permissions are required to get back. However, problems may arise in the revocation process when one user delegates user U a role and another user delegates U a negative authorization of the role. This paper aims to analyse various role-based delegation revocation features through examples. Revocations are categorized in four dimensions: Dependency, Resilience, Propagation and Dominance. According to these dimensions, sixteen types of revocations exist for specific requests in collaborative business environments: DependentWeakLocalDelete, Dependent WeakLocalNegative, DependentWeakGlobalDelete, DependentWeakGlobalNegative, IndependentWeak LocalDelete, IndependentWeakLocalNegative, Inde pendentWeakGlobalDelete, IndependentWeakGlobal Negative, and so on. We present revocation delegating models, and then discuss user delegation authorization and the impact of revocation operations. Finally, comparisons with other related work are discussed

Effects of anesthesia on conventional and speckle tracking echocardiographic parameters in a mouse model of pressure overload

Genetically‑modified mice are widely applied in cardiovascular studies as model organisms. Echocardiography is a key tool for evaluating cardiac and hemodynamic functions in mice. The present study aimed to examine the effects of isoflurane (ISF) on conventional and speckle tracking echocardiography (STE) parameters under healthy and pathological conditions using a murine model of pressure overload. In addition, the optimal dose of ISF in the process of echocardiographic measurement, with minimum cardiac contraction depression, was investigated. Conventional echocardiographic and STE examinations were performed on 38 adult C57BL/6 male mice. The mice were divided into the following three groups: The sham (n=15); mild thoracic aortic banding (TAB; n=15); and severe TAB (n=8) groups. ISF was administered under deep anesthesia (DA; 1‑2% ISF), light anesthesia (LA; 0.5‑1% ISF) and immediately prior to the mice waking up (awake; 0‑0.5% ISF). Conventional echocardiographic parameters were preserved within the sham and mild TAB groups (P>0.05 for each parameter) under LA and awake conditions. However, under DA conditions, the majority of these parameters were reduced compared with the LA and awake conditions (P<0.05). In the severe TAB group, conventional echocardiographic parameters remained constant under LA, DA and awake conditions. STE parameters in the groups remained similar between the LA and awake conditions, but were significantly reduced under DA conditions. Therefore, conventional echocardiography and STE may be performed using LA induced with low doses of ISF, under various pathological conditions without affecting cardiac function

Definition and Design of Zero Energy Buildings

The wide application of renewable energy system (RES) in buildings combined with numerous financial incentives on RES paves the way for future zero energy buildings (ZEB). Although the definition of ZEB still lacks a national building code and international standards, the number of ZEB projects is still increasing worldwide which seems to be the pioneer ZEB buildings. However, due to the intermittency of the renewable resources, various uncertain parameters, and dynamic electricity price from the grid, how to select the renewable energy system for buildings is one of the challenges and therefore becomes an extensive concern for both researchers and designers. In addition, questions like how to achieve the target of zero energy for different types of buildings, should the building be designed as an independent ZEB or a group of buildings to be a ZEB cluster, and how to make building owners actively involved in installing enough RES for the building are still on the air. This chapter will present a comprehensive view on several key issues related with ZEB, that is, definition, evaluation criteria, design method, and uncertainty analysis, and the penalty cost scheme is also proposed for consideration as one policy to assist the promotion of ZEB

A coordinated control method of voltage and reactive power for active distribution net-works based on soft open point

The increasing penetration of distributed generators (DGs) exacerbates the risk of voltage violations in active distribu-tion networks (ADNs). The conventional voltage regulation de-vices limited by the physical constraints are difficult to meet the requirement of real-time voltage and VAR control (VVC) with high precision when DGs fluctuate frequently. However, soft open point (SOP), a flexible power electronic device, can be used as the continuous reactive power source to realize the fast voltage regu-lation. Considering the cooperation of SOP and multiple regula-tion devices, this paper proposes a coordinated VVC method based on SOP for ADNs. Firstly, a time-series model of coordi-nated VVC is developed to minimize operation costs and eliminate voltage violations of ADNs. Then, by applying the linearization and conic relaxation, the original nonconvex mixed-integer non-linear optimization model is converted into a mixed-integer sec-ond-order cone programming (MISOCP) model which can be efficiently solved to meet the requirement of voltage regulation rapidity. Case studies are carried out on the IEEE 33-node system and IEEE 123-node system to illustrate the effectiveness of the proposed method

3-Methyl­quinoxaline-2-carb­oxy­lic acid 4-oxide monohydrate

In the crystal structure of the title compound, C10H8N2O3·H2O, mol­ecules are linked via inter­molecular O—H⋯O and O—H⋯N hydrogen bonds into a two-dimensional network

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities

Since the successful application of messenger RNA (mRNA) vaccines in preventing COVID-19, researchers have been striving to develop mRNA vaccines for clinical use, including those exploited for anti-tumor therapy. mRNA cancer vaccines have emerged as a promising novel approach to cancer immunotherapy, offering high specificity, better efficacy, and fewer side effects compared to traditional treatments. Multiple therapeutic mRNA cancer vaccines are being evaluated in preclinical and clinical trials, with promising early-phase results. However, the development of these vaccines faces various challenges, such as tumor heterogeneity, an immunosuppressive tumor microenvironment, and practical obstacles like vaccine administration methods and evaluation systems for clinical application. To address these challenges, we highlight recent advances from preclinical studies and clinical trials that provide insight into identifying obstacles associated with mRNA cancer vaccines and discuss potential strategies to overcome them. In the future, it is crucial to approach the development of mRNA cancer vaccines with caution and diligence while promoting innovation to overcome existing barriers. A delicate balance between opportunities and challenges will help guide the progress of this promising field towards its full potential

The ARF tumor suppressor targets PPM1G/PP2Cγ to counteract NF-κB transcription tuning cell survival and the inflammatory response

Inducible transcriptional programs mediate the regulation of key biological processes and organismal functions. Despite their complexity, cells have evolved mechanisms to precisely control gene programs in response to environmental cues to regulate cell fate and maintain normal homeostasis. Upon stimulation with proinflammatory cytokines such as tumor necrosis factor-α (TNF), the master transcriptional regulator nuclear factor (NF)-κB utilizes the PPM1G/PP2Cγ phosphatase as a coactivator to normally induce inflammatory and cell survival programs. However, how PPM1G activity is precisely regulated to control NF-κB transcription magnitude and kinetics remains unknown. Here, we describe a mechanism by which the ARF tumor suppressor binds PPM1G to negatively regulate its coactivator function in the NF-κB circuit thereby promoting insult resolution. ARF becomes stabilized upon binding to PPM1G and forms a ternary protein complex with PPM1G and NF-κB at target gene promoters in a stimulidependent manner to provide tunable control of the NF-κB transcriptional program. Consistently, loss of ARF in colon epithelial cells leads to up-regulation of NF-κB antiapoptotic genes upon TNF stimulation and renders cells partially resistant to TNFinduced apoptosis in the presence of agents blocking the antiapoptotic program. Notably, patient tumor data analysis validates these findings by revealing that loss of ARF strongly correlates with sustained expression of inflammatory and cell survival programs. Collectively, we propose that PPM1G emerges as a therapeutic target in a variety of cancers arising from ARF epigenetic silencing, to loss of ARF function, as well as tumors bearing oncogenic NF-κB activation.Fil: Hyder, Usman. University of Texas; Estados UnidosFil: McCann, Jennifer L.. University of Texas; Estados UnidosFil: Wang, Jinli. University of Texas; Estados UnidosFil: Fung, Victor. University of Texas; Estados UnidosFil: Bayo Fina, Juan Miguel. Universidad Austral. Facultad de Ciencias Biomédicas. Instituto de Investigaciones en Medicina Traslacional. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones en Medicina Traslacional; ArgentinaFil: D'Orso, Iván. University of Texas; Estados Unido